Abstract:Objective Investigate the expression of SORT1 in elderly pancreatic cancer tissues and its impact on patient prognosis and the underlying mechanisms. Methods Pancreatic cancer tissues and adjacent normal tissues were obtained from 39 elderly pancreatic cancer patients. The expression levels of SORT1 were detected using immunohistochemical staining, and its correlation with various clinical-pathological characteristics and prognosis was analyzed. SORT1 co-expressed genes were screened using data from the Gene Expression Omnibus Database, the Gene Expression Profiling Interactive Analysis Database, and the GeneCards genomic annotation platform, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and Gene Ontology (GO) functional annotation were performed on these genes using the Sangerbox bioinformatics analysis platform. Results The expression rate of SORT1 in pancreatic cancer tissues (71.8%, 28/39) was significantly higher than that in adjacent normal tissues (7.7%, 3/39), with a statistically significant difference (χ2=33.46,P<0.001). The expression level of SORT1 was correlated with tumor size and pathological grade (P<0.05). Cox proportional hazards regression analysis indicated that high SORT1 expression was an independent risk factor for poor prognosis in elderly pancreatic cancer patients (HR=2.354,95%CI 1.062-5.213; P=0.036). Kaplan-Meier survival analysis demonstrated that the survival rate of patients with high SORT1 expression was significantly lower than that of those with low expression, with a statistically significant difference (66.7% vs 81.8%; χ2=6.443, P=0.011). The venn analysis identified 221 SORT1 co-expressed genes. KEGG analysis revealed that these genes were primarily enriched in the endocytosis pathway (P=0.000 19). GO analysis revealed that SORT1 was primarily localized in the cytoplasm (P<0.000 1), bound to enzymes (P<0.000 1), and participated in vesicle trafficking (P=0.000 3). Conclusion SORT1 is highly expressed in pancreatic cancer tissues of elderly patients , and its expression level shows significant correlated with tumor size and pathological grade. High SORT1 expression is an independent risk factor influencing the prognosis of elderly pancreatic cancer patients. SORT1 may regulate the pancreatic cancer progression through such as vesicle-mediated transport and endocytosis. SORT1 is expected to become a potential target for prognostic evaluation and treatment of pancreatic cancer in elderly patients.